amikacin has been researched along with Cholecystoduodenal Fistula in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gil-Romero, Y; Gómez-Garcés, JL; Merino, F; Vazquez, O | 1 |
| Cai, WM; Chen, G; Yu, GH | 1 |
2 other study(ies) available for amikacin and Cholecystoduodenal Fistula
| Article | Year |
|---|---|
[Synergistic activity and clinical efficacy of fosfomycin and ciprofloxacin combination treatment for soft tissue infection caused by carbapenemase-producing Enterobacter cloacae].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Colonic Diseases; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Hernia, Abdominal; Herniorrhaphy; Humans; Intestinal Fistula; Minocycline; Postoperative Complications; Prosthesis-Related Infections; Soft Tissue Infections; Surgical Mesh; Tigecycline | 2017 |
[Influence of total parenteral nutrition on amikacin pharmacokinetics].
Topics: Adult; Aged; Amikacin; Humans; Intestinal Fistula; Male; Middle Aged; Parenteral Nutrition, Total | 1989 |